Group 1 - The sixth batch of national organized high-value medical consumables centralized procurement results has been announced, covering 12 types of medical consumables related to drug-coated balloons and urological interventions, with 202 companies and 440 products selected [1] - This procurement marks the first time that various key consumables required for urological stone surgery have been included, such as ureteral intervention guidewires and balloons, with 170 companies and 398 products selected [1] - The inclusion of these consumables is expected to significantly reduce the overall treatment costs for stone diseases, which previously ranged from 20,000 to 30,000 yuan for minimally invasive surgeries [1] Group 2 - A total of 32 companies participated in the bidding for drug-coated balloons, with all 42 products selected, indicating a high match with clinical usage and potential to alleviate the financial burden on patients [1] - The procurement process adhered to the principle of "anti-involution," employing group competition to ensure that clinically recognized and capable products were selected, thereby stabilizing clinical usage [1] - For differentiated products with certain functional innovations, a pricing coefficient based on clinical value was established to reasonably reflect price differences and enrich clinical usage [1]
首次采购泌尿系统结石手术相关耗材
Xin Lang Cai Jing·2026-01-14 18:39